Senores Pharmaceuticals Limited has announced the closure of its trading window for directors, promoters, designated persons, and their immediate relatives. The window will remain closed from January 01, 2026, until 48 hours after the announcement of the unaudited financial results for the quarter and nine months ending December 31, 2025. All concerned individuals are advised against trading in the company's securities during this period. The specific date for the Board Meeting to approve these financial results will be intimated separately. This closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for preventing insider trading.